KPJ Healthcare Berhad (5878.KL)
MYR 2.4
(1.69%)
MYR 2.4
(1.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 814.46 Million MYR | 1.36% |
| 2022 | 683.1 Million MYR | 34.43% |
| 2021 | 513.17 Million MYR | -2.69% |
| 2020 | 537.9 Million MYR | -15.54% |
| 2019 | 614.38 Million MYR | 27.99% |
| 2018 | 469.29 Million MYR | 15.17% |
| 2017 | 444.24 Million MYR | 4.45% |
| 2016 | 432.9 Million MYR | 8.24% |
| 2015 | 392.93 Million MYR | 6.1% |
| 2014 | 370.34 Million MYR | 26.64% |
| 2013 | 292.43 Million MYR | -2.13% |
| 2012 | 261.32 Million MYR | 1.77% |
| 2011 | 293.59 Million MYR | 22.07% |
| 2010 | 240.5 Million MYR | 16.16% |
| 2009 | 208.43 Million MYR | 18.91% |
| 2008 | 155.41 Million MYR | 17.64% |
| 2007 | 135.64 Million MYR | 31.42% |
| 2006 | 112.61 Million MYR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 214 Million MYR | -7.26% |
| 2024 Q1 | 187.57 Million MYR | 40.71% |
| 2023 Q2 | 186.14 Million MYR | -3.93% |
| 2023 FY | - MYR | 1.36% |
| 2023 Q3 | 265.49 Million MYR | 42.63% |
| 2023 Q4 | 174.26 Million MYR | -34.36% |
| 2023 Q1 | 193.76 Million MYR | -4.41% |
| 2022 Q3 | 205.87 Million MYR | 25.61% |
| 2022 FY | - MYR | 34.43% |
| 2022 Q4 | 202.7 Million MYR | -1.54% |
| 2022 Q2 | 163.9 Million MYR | 5.94% |
| 2022 Q1 | 154.71 Million MYR | 9.94% |
| 2021 Q4 | 140.72 Million MYR | -5.91% |
| 2021 FY | - MYR | -2.69% |
| 2021 Q1 | 128.55 Million MYR | 1.16% |
| 2021 Q3 | 149.57 Million MYR | 25.37% |
| 2021 Q2 | 119.3 Million MYR | -7.2% |
| 2020 Q4 | 127.07 Million MYR | -17.97% |
| 2020 FY | - MYR | -15.54% |
| 2020 Q1 | 155.67 Million MYR | -16.71% |
| 2020 Q2 | 115.37 Million MYR | -25.89% |
| 2020 Q3 | 154.91 Million MYR | 34.27% |
| 2019 Q1 | 156.59 Million MYR | 3.96% |
| 2019 Q2 | 157.96 Million MYR | 0.87% |
| 2019 Q4 | 186.9 Million MYR | 16.41% |
| 2019 Q3 | 160.55 Million MYR | 1.64% |
| 2019 FY | - MYR | 27.99% |
| 2018 Q2 | 121.37 Million MYR | 2.65% |
| 2018 Q3 | 121.39 Million MYR | 0.02% |
| 2018 FY | - MYR | 15.17% |
| 2018 Q1 | 118.23 Million MYR | -5.13% |
| 2018 Q4 | 150.63 Million MYR | 24.09% |
| 2017 Q3 | 105.24 Million MYR | 4.11% |
| 2017 Q4 | 124.62 Million MYR | 18.41% |
| 2017 FY | - MYR | 4.45% |
| 2017 Q1 | 107.58 Million MYR | -12.07% |
| 2017 Q2 | 101.09 Million MYR | -6.03% |
| 2016 Q1 | 104.78 Million MYR | 9.73% |
| 2016 FY | - MYR | 8.24% |
| 2016 Q2 | 94.61 Million MYR | -9.71% |
| 2016 Q4 | 122.35 Million MYR | 18.71% |
| 2016 Q3 | 103.06 Million MYR | 8.93% |
| 2015 FY | - MYR | 6.1% |
| 2015 Q1 | 96.06 Million MYR | -8.39% |
| 2015 Q2 | 98.38 Million MYR | 2.41% |
| 2015 Q3 | 102.99 Million MYR | 4.69% |
| 2015 Q4 | 95.49 Million MYR | -7.29% |
| 2014 Q3 | 94.93 Million MYR | 4.33% |
| 2014 FY | - MYR | 26.64% |
| 2014 Q4 | 104.85 Million MYR | 10.45% |
| 2014 Q2 | 90.99 Million MYR | 14.37% |
| 2014 Q1 | 79.56 Million MYR | -18.82% |
| 2013 FY | - MYR | -2.13% |
| 2013 Q4 | 98.01 Million MYR | 58.01% |
| 2013 Q3 | 62.03 Million MYR | -11.6% |
| 2013 Q2 | 70.16 Million MYR | 12.76% |
| 2013 Q1 | 62.22 Million MYR | -11.1% |
| 2012 Q4 | 69.99 Million MYR | -8.81% |
| 2012 FY | - MYR | 1.77% |
| 2012 Q1 | 73.03 Million MYR | 0.0% |
| 2012 Q2 | 79.01 Million MYR | 8.18% |
| 2012 Q3 | 76.75 Million MYR | -2.86% |
| 2011 FY | - MYR | 22.07% |
| 2010 FY | - MYR | 16.16% |
| 2009 FY | - MYR | 18.91% |
| 2008 FY | - MYR | 17.64% |
| 2007 FY | - MYR | 31.42% |
| 2006 FY | - MYR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| TMC Life Sciences Berhad | 90.78 Million MYR | -797.181% |
| IHH Healthcare Berhad | 6.28 Billion MYR | 87.034% |